Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Quast

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Developments in Biological Standardization|January 1, 1979
BCG vaccination of neonates, infants, schoolchildren and adolescents. Part II: Safety of a vaccine with strain 1331 CopenhagenH G Lehmann, H Engelhardt, H Freudenstein, et al.
Strahlentherapie|July 1, 1979
Multidetector endodosimetry probe with silicon-pn-junction-diodes for in-vivo-dosimetryU Quast, J F Goncalves, K H Schick, et al.
Biochemical Pharmacology|November 25, 1998
Effects of ions on adenosine binding and enzyme activity of purified S-adenosylhomocysteine hydrolase from bovine kidneyD Kloor, S Fuchs, F Petroktistis, et al.
Molecular Pharmacology|March 1, 1993
Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockersU Quast, K M Bray, H Andres, et al.
Journal of Cardiovascular Pharmacology|May 1, 1992
Chronic adriamycin treatment and its effect on the cardiac beta-adrenergic system in the rabbitS A Bocherens-Gadient, U Quast, J Nussberger, et al.
Biochemistry|June 13, 1978
Ligand-induced conformation changes in Torpedo californica membrane-bound acetylcholine receptorU Quast, M Schimerlik, T Lee, et al.
Molecular Pharmacology|April 30, 1999
ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADPA Hambrock, C Löffler-Walz, D Kloor, et al.
Molecular Pharmacology|October 26, 1999
Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamideU Russ, A Hambrock, F Artunc, et al.
Strahlentherapie|January 1, 1980
[Therapy and prognosis of the medulloblastoma: progress through late irradiation techniques (author's transl)]M Bamberg, G Schmitt, U Quast, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1997
Dosimetry and design of radioactive eye plaquesD Flühs, M Bambynek, M Heintz, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Developments in Biological Standardization|January 1, 1979
BCG vaccination of neonates, infants, schoolchildren and adolescents. Part II: Safety of a vaccine with strain 1331 CopenhagenH G Lehmann, H Engelhardt, H Freudenstein, et al.
Strahlentherapie|July 1, 1979
Multidetector endodosimetry probe with silicon-pn-junction-diodes for in-vivo-dosimetryU Quast, J F Goncalves, K H Schick, et al.
Biochemical Pharmacology|November 25, 1998
Effects of ions on adenosine binding and enzyme activity of purified S-adenosylhomocysteine hydrolase from bovine kidneyD Kloor, S Fuchs, F Petroktistis, et al.
Molecular Pharmacology|March 1, 1993
Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockersU Quast, K M Bray, H Andres, et al.
Journal of Cardiovascular Pharmacology|May 1, 1992
Chronic adriamycin treatment and its effect on the cardiac beta-adrenergic system in the rabbitS A Bocherens-Gadient, U Quast, J Nussberger, et al.
Biochemistry|June 13, 1978
Ligand-induced conformation changes in Torpedo californica membrane-bound acetylcholine receptorU Quast, M Schimerlik, T Lee, et al.
Molecular Pharmacology|April 30, 1999
ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADPA Hambrock, C Löffler-Walz, D Kloor, et al.
Molecular Pharmacology|October 26, 1999
Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamideU Russ, A Hambrock, F Artunc, et al.
Strahlentherapie|January 1, 1980
[Therapy and prognosis of the medulloblastoma: progress through late irradiation techniques (author's transl)]M Bamberg, G Schmitt, U Quast, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1997
Dosimetry and design of radioactive eye plaquesD Flühs, M Bambynek, M Heintz, et al.
Pageof 17